How much is Solarea Bio worth in 2026?

Solarea Bio has a current valuation of $37.0M based on their Later Stage VC round and secondary market data.

How much funding has Solarea Bio raised?

Solarea Bio has raised $37.4M in total funding across 2 funding rounds.

Solarea Bio

Drug DiscoveryWebsite

Solarea Bio valuation and funding history | Last updated: November 19, 2025 | 2 funding rounds

Current Valuation

$37.0M

As of November 19, 2025

Total Funding Raised

$37.4M

Across 2 rounds

Last Round

Later Stage VC

$9.9M

Last Funding

Nov 2025

Funding date

Capital Efficiency

0.99x

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
May 8, 2023	Later Stage VC (Series B)	$15.0M	N/A	-
September 11, 2020	Early Stage VC (Series A)	$11.3M	N/A	-

Valuation Analysis

Current Valuation Metrics

Solarea Bio is currently valued at $37.0M as of November 19, 2025. The company has raised a total of $37.4M in funding across 2 funding rounds.

Capital Efficiency

With a capital efficiency ratio of 0.99x, Solarea Bio has achieved a valuation that is 0.99 times the total capital raised.

Track Solarea Bio Valuation Updates

Get notified when Solarea Bio raises new funding or valuation changes

Explore More Data

Detailed analysis for Solarea Bio

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Solarea Bio's valuation history, funding rounds, and growth metrics.

No credit card required

What is Solarea Bio Worth in 2026?

Solarea Bio is a leading private company in the Drug Discovery sector. Track Solarea Bio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Solarea Bio Valuation is Determined

Private company valuations like Solarea Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.